ENSC - CIK 0001716947
Ensysce Biosciences, Inc. (ENSC) reported revenue of $5.07M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $5.07M | -2.8% |
| FY 2024 | $5.21M | +133.6% |
| FY 2023 | $2.23M | -11.6% |
| FY 2022 | $2.52M | -28.5% |
| FY 2021 | $3.53M | -10.2% |
| FY 2020 | $3.93M | - |
Ensysce Biosciences, Inc. (ENSC) reported revenue of $5.07M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Ensysce Biosciences, Inc.'s revenue grew from $3.93M to $5.07M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.